Kush Parmar
10% Owner at Skye Bioscience, Inc. (SKYE); Director at Entrada Therapeutics, Inc. (TRDA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 18SEC | SKYESkye Bioscience, Inc. | Sell | 32,607142,463 held (−19%) | $1.91 | $62K | -11.5% |
| Sep 18SEC | SKYESkye Bioscience, Inc. | Sell | 1,2855,616 held (−19%) | $1.91 | $2K | -11.5% |
| Aug 10SEC | TRDAEntrada Therapeutics, Inc. | Sell | 10,4942,836,098 held (−0%) | $7.00 | $73K | -19.0% |
| Aug 10SEC | TRDAEntrada Therapeutics, Inc. | Sell | 52,3172,783,781 held (−2%) | $6.85 | $358K | -17.2% |
| Aug 10SEC | TRDAEntrada Therapeutics, Inc. | Sell | 92,4442,691,337 held (−3%) | $7.00 | $647K | -19.0% |
| Aug 3SEC | TRDAEntrada Therapeutics, Inc. | Sell | 114,7562,848,310 held (−4%) | $6.93 | $795K | -18.2% |
| Aug 3SEC | TRDAEntrada Therapeutics, Inc. | Sell | 1,7182,846,592 held (−0%) | $6.85 | $12K | -17.2% |
| Nov 18SEC | TRDAEntrada Therapeutics, Inc. | Sell | 200,0002,963,066 held (−6%) | $8.80 | $1.8M | -35.6% |